These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 16321523)

  • 1. Sarcosine based indandione hGlyT1 inhibitors.
    Thomson CG; Duncan K; Fletcher SR; Huscroft IT; Pillai G; Raubo P; Smith AJ; Stead D
    Bioorg Med Chem Lett; 2006 Mar; 16(5):1388-91. PubMed ID: 16321523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitors of GlyT1 affect glycine transport via discrete binding sites.
    Mezler M; Hornberger W; Mueller R; Schmidt M; Amberg W; Braje W; Ochse M; Schoemaker H; Behl B
    Mol Pharmacol; 2008 Dec; 74(6):1705-15. PubMed ID: 18815213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transmembrane domains 1 and 3 of the glycine transporter GLYT1 contain structural determinants of N[3-(4'-fluorophenyl)-3-(4'-phenylphenoxy)-propyl]sarcosine specificity.
    Núñez E; Martínez-Maza R; Geerlings A; Aragón C; López-Corcuera B
    Neuropharmacology; 2005 Nov; 49(6):922-34. PubMed ID: 16143353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and SAR of GlyT1 inhibitors derived from a series of N-((4-(morpholine-4-carbonyl)-1-(propylsulfonyl)piperidin-4-yl)methyl)benzamides.
    Zhao Z; O'Brien JA; Lemaire W; Williams DL; Jacobson MA; Sur C; Pettibone DJ; Tiller PR; Smith S; Hartman GD; Wolkenberg SE; Lindsley CW
    Bioorg Med Chem Lett; 2006 Dec; 16(23):5968-72. PubMed ID: 16987662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sarcosine-Based Glycine Transporter Type-1 (GlyT-1) Inhibitors Containing Pyridazine Moiety: A Further Search for Drugs with Potential to Influence Schizophrenia Negative Symptoms.
    Harsing LG; Timar J; Szabo G; Udvari S; Nagy KM; Marko B; Zsilla G; Czompa A; Tapolcsanyi P; Kocsis A; Matyus P
    Curr Pharm Des; 2015; 21(17):2291-303. PubMed ID: 25578890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acylglycinamides as inhibitors of glycine transporter type 1.
    Blunt R; Porter R; Johns A; Nash D; Puckey G; Wyman P; Herdon H; Teague S; Hadden V; Fontana S; Gordon L
    Bioorg Med Chem Lett; 2011 Oct; 21(20):6176-9. PubMed ID: 21889344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design of potent GlyT1 inhibitors: in vitro and in vivo profiles.
    Bridges TM; Williams R; Lindsley CW
    Curr Opin Mol Ther; 2008 Dec; 10(6):591-601. PubMed ID: 19051137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery and SAR studies of novel GlyT1 inhibitors.
    Walter MW; Hoffman BJ; Gordon K; Johnson K; Love P; Jones M; Man T; Phebus L; Reel JK; Rudyk HC; Shannon H; Svensson K; Yu H; Valli MJ; Porter WJ
    Bioorg Med Chem Lett; 2007 Sep; 17(18):5233-8. PubMed ID: 17629697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimisation of a series of potent, selective and orally bioavailable GlyT1 inhibitors.
    Thomson JL; Blackaby WP; Jennings AS; Goodacre SC; Pike A; Thomas S; Brown TA; Smith A; Pillai G; Street LJ; Lewis RT
    Bioorg Med Chem Lett; 2009 Apr; 19(8):2235-9. PubMed ID: 19318248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glutamate-based therapeutic approaches: inhibitors of glycine transport.
    Lechner SM
    Curr Opin Pharmacol; 2006 Feb; 6(1):75-81. PubMed ID: 16376148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo evaluation of carbon-11-labelled non-sarcosine-based glycine transporter 1 inhibitors in mice and conscious monkeys.
    Toyohara J; Ishiwata K; Sakata M; Wu J; Nishiyama S; Tsukada H; Hashimoto K
    Nucl Med Biol; 2011 May; 38(4):517-27. PubMed ID: 21531289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of benzoylpiperazines as a novel class of potent and selective GlyT1 inhibitors.
    Pinard E; Alberati D; Borroni E; Fischer H; Hainzl D; Jolidon S; Moreau JL; Narquizian R; Nettekoven M; Norcross RD; Stalder H; Thomas AW
    Bioorg Med Chem Lett; 2008 Sep; 18(18):5134-9. PubMed ID: 18752953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The discovery of a structurally novel class of inhibitors of the type 1 glycine transporter.
    Lowe JA; Hou X; Schmidt C; David Tingley F; McHardy S; Kalman M; Deninno S; Sanner M; Ward K; Lebel L; Tunucci D; Valentine J; Bronk BS; Schaeffer E
    Bioorg Med Chem Lett; 2009 Jun; 19(11):2974-6. PubMed ID: 19410451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of N-(2-aryl-cyclohexyl) substituted spiropiperidines as a novel class of GlyT1 inhibitors.
    Pinard E; Ceccarelli SM; Stalder H; Alberati D
    Bioorg Med Chem Lett; 2006 Jan; 16(2):349-53. PubMed ID: 16246557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis and structure-activity relationship of simple bis-amides as potent inhibitors of GlyT1.
    Jolidon S; Alberati D; Dowle A; Fischer H; Hainzl D; Narquizian R; Norcross R; Pinard E
    Bioorg Med Chem Lett; 2008 Oct; 18(20):5533-6. PubMed ID: 18805008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurochemical and behavioral profiling of the selective GlyT1 inhibitors ALX5407 and LY2365109 indicate a preferential action in caudal vs. cortical brain areas.
    Perry KW; Falcone JF; Fell MJ; Ryder JW; Yu H; Love PL; Katner J; Gordon KD; Wade MR; Man T; Nomikos GG; Phebus LA; Cauvin AJ; Johnson KW; Jones CK; Hoffmann BJ; Sandusky GE; Walter MW; Porter WJ; Yang L; Merchant KM; Shannon HE; Svensson KA
    Neuropharmacology; 2008 Oct; 55(5):743-54. PubMed ID: 18602930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycine transporter inhibitors as a potential therapeutic strategy for chronic pain with memory impairment.
    Tanabe M; Takasu K; Yamaguchi S; Kodama D; Ono H
    Anesthesiology; 2008 May; 108(5):929-37. PubMed ID: 18431130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional expression of the glycine transporter 1 on bullfrog retinal cones.
    Zhang XJ; Ge LH; Liu J; Yang XL
    Neuroreport; 2008 Nov; 19(17):1667-71. PubMed ID: 18841092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 1,3-diaminopropan-2-ol sulfonamides as potent and selective inhibitors of the glycine transporter type 1.
    Rahman SS; Coulton S; Herdon HJ; Joiner GF; Jin J; Porter RA
    Bioorg Med Chem Lett; 2007 Mar; 17(6):1741-5. PubMed ID: 17234406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of the glycine transporter GlyT-1 potentiates the effect of risperidone, but not clozapine, on glutamatergic transmission in the rat medial prefrontal cortex.
    Konradsson A; Marcus MM; Hertel P; Svensson TH; Jardemark KE
    Synapse; 2006 Aug; 60(2):102-8. PubMed ID: 16715496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.